Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2025-12-25 @ 3:44 AM
NCT ID:
NCT03467802
Eligibility Criteria:
Inclusion Criteria:
* Age 18 years or over
* Patient will remain in the Capital region for at least 6 months following the surgical procedure for follow up appointments
* Patient must be otherwise periodontally healthy
* Patient must be systemically healthy (ASA class I or II)
* Patient must have no contraindications to periodontal surgery
* Patient must have demonstrated good oral hygiene (plaque index \<1 according to Silness and Löe)
* Paired Miller Class I, II or predictable III recession defects
* Bilateral, facial defects on single-rooted teeth
Exclusion Criteria:
* Self-reported history of smoking within previous 6 months
* Does not meet any of the preceding criteria
* Female patients who are pregnant or nursing
* Antibiotic medications taken within the last 6 months
* History of mucogingival surgery at the sites of interest
* Poor plaque control (\>25% of sites)
* Those with clinically significant systemic disease, which may affect healing (i.e. uncontrolled diabetes or bone metabolic disease)
* Allergy to chlorhexidine gluconate (Peridex)
* Does not sign study consent or HIPAA forms
* Bleeding complications (e.g. hemophilia)
* Warfarin therapy
* History of osteoporosis or taking bisphosphonate medications
* History of radiation therapy in the head and neck area
* Mobile teeth beyond physiologic mobility
* Facial restorations at the site to be treated
* Recession defects that will require more than one 15x20mm Mucograft (per side)
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03467802
Study Brief:
Protocol Section:
NCT03467802